4
Changes in Ownership
IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-21-082064
Options or other derivatives
- Interim CEO & General Counsel acquired 173,900 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Vogt Frederick G Interim CEO & General Counsel | 2021-06-14 | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | D: show line 1 in the form | ||
| Vogt Frederick G Interim CEO & General Counsel | 2021-06-14 | Grant or award · Stock Option (right to buy) | +73,900 | 73,900 | D: show line 2 in the form |
Loading xslF345X03/tm2119923-1_4seq1.xml…